Sangoma Technologies Corporation (SANG) closed the last trading session at $5.95, gaining 29.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.36 indicates a 40.5% upside potential.The average comprises four short-term price targets ranging from a low of $7.94 to a high of $9.50, with a standard deviation of $0.76. While the lowest estimate indicates an increase of 33.5% from t ...

Crexendo (CXDO) closed the last trading session at $5.81, gaining 24.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.30 indicates a 42.9% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $0.97. While the lowest estimate of $7.50 indicates a 29.1% increase from the current price level, the most optimistic analyst expects t ...

uniQure (QURE) closed the last trading session at $12.81, gaining 32.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $33.50 indicates a 161.5% upside potential.The average comprises 10 short-term price targets ranging from a low of $20 to a high of $70, with a standard deviation of $15.33. While the lowest estimate indicates an increase of 56.1% from the current price level, the ...

Core Viewpoint - BioLife Solutions, Inc. (BLFS) shares have increased by 8.2% recently, with a mean price target of $31.22 suggesting a potential upside of 30.7% from the current price of $23.89 [1] Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $1.48, indicating variability among analysts [2] - The lowest price target is $30, representing a 25.6% increase, while the highest target is $34, indicating a potential surge of 42.3% [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Sentiment - Analysts are optimistic about BLFS's earnings prospects, as indicated by a positive trend in earnings estimate revisions [4][11] - The Zacks Consensus Estimate for the current year has risen by 19.2% over the past month, with no negative revisions [12] - BLFS holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13]

Shares of AudioEye (AEYE) have gained 14.3% over the past four weeks to close the last trading session at $12.90, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $22.40 indicates a potential upside of 73.6%.The mean estimate comprises five short-term price targets with a standard deviation of $2.51. While the lowest estimate of $20 indicates a 55% increase from the current price ...

Shares of Beyond (BYON) have gained 30.8% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $12.83 indicates a potential upside of 156.1%.The mean estimate comprises six short-term price targets with a standard deviation of $12.16. While the lowest estimate of $5 indicates a 0.2% decline from the current price le ...

Shares of Honest (HNST) have gained 14.5% over the past four weeks to close the last trading session at $5.07, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $7.14 indicates a potential upside of 40.8%.The mean estimate comprises seven short-term price targets with a standard deviation of $0.85. While the lowest estimate of $5.50 indicates an 8.5% increase from the current pric ...

Shares of Kemper (KMPR) have gained 12.8% over the past four weeks to close the last trading session at $65.52, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $82.20 indicates a potential upside of 25.5%.The mean estimate comprises five short-term price targets with a standard deviation of $5.72. While the lowest estimate of $75 indicates a 14.5% increase from the current price ...

Core Viewpoint - Centrus Energy Corp. (LEU) has shown a significant price increase of 46% over the past four weeks, with a mean price target of $148.33 indicating a potential upside of 56.6% from the current price of $94.71 [1] Price Targets and Analyst Consensus - The average price target for LEU includes six short-term estimates, ranging from a low of $69 to a high of $300, with a standard deviation of $79.84, indicating variability in analyst estimates [2] - The lowest estimate suggests a decline of 27.2%, while the highest points to a potential upside of 216.8% [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Optimism - Analysts are optimistic about LEU's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a 9.9% increase in the Zacks Consensus Estimate over the past month [11][12] - The company currently holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after by investors, they can be misleading and should not be the sole basis for investment decisions [3][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - 10x Genomics (TXG) shares have increased by 14.7% recently, with a mean price target of $14.79 suggesting a potential upside of 55.9% from the current price of $9.49 [1][2] Price Targets and Analyst Estimates - The mean estimate consists of 14 short-term price targets with a standard deviation of $3.79, indicating variability among analysts [2] - The lowest estimate of $11 indicates a 15.9% increase, while the highest estimate suggests a 174% surge to $26 [2] - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10] Earnings Estimates and Analyst Agreement - Analysts are optimistic about TXG's earnings prospects, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 14.6%, with five estimates moving higher and no negative revisions [12] - TXG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]